Events WORKING GROUP HEALTH

Lunch debate of the Working Group on Health

Working Group on Health taking place on Tuesday, 03 December 2024 at 13.00 hrs in the European Parliament Brussels, Salon Privé/Restaurant des Députés.

We will discuss: "Boosting EU Competitiveness: Empowering innovative small and mid-sized companies in the pharmaceutical sector"

The European Commission has included competitiveness as a key priority in its new mandate, including for the pharmaceutical sector, which is currently undergoing a significant overhaul with the revision of the General Pharmaceutical Legislation (GPL). To remain globally competitive, the EU pharmaceutical industry needs a robust and predictable incentives, regulatory and industrial ecosystem. This will help spur innovation, bring new therapies to patients and promote a sustainable healthcare ecosystem for the EU and its Member States. The event aims to discuss and identify actionable strategies to enhance competitiveness of the EU pharmaceutical sector, with a particular focus on small and mid-sized innovative companies.

Welcome and Introduction:

Michael GAHLER MEP, President of the Kangaroo Group

Speaker:

Kristian VIGENIN MEP, S&D/Bulgaria, Member of the Committee on the Environment, Public Health and Food Safety 

Alexander NATZ, Secretary General, EUCOPE

This event is a paying event, the  contribution is :
20€ for MEPs, EU-officials, Kangaroo Group Members and 90€ for Non-Members  –  to be paid in cash at the reception desk in front of the venue –

Click here to register

Working Group HEALTH

Wednesday, 29 January 2020 from 13:00 to 14:30 hrs

“EU Industrial Policy: Challenges and Opportunities for the new mandate”

Speakers:

Cristian Silviu BUSOI MEP, EPP/Romania, Chair of the Committee on Industry, Research and Industry

Timo PESONEN, Director General, DG GROW

Marc-Antoine LUCCHINI, Senior Vice-President, Head of Primary Care Europe and Coordinator, Sanofi Europe

Dr. Gerd KRAEH, Senior Director Government Affairs/ Lilly Deutschland GmbH and Committee Chair for International and European Affairs of the German Association for Research-Based Pharmaceutical Companies (vfa)